|Bid||74.47 x 14900|
|Ask||75.22 x 14800|
|Day's Range||74.37 - 74.37|
|52 Week Range||38.47 - 80.96|
|Beta (5Y Monthly)||1.77|
|PE Ratio (TTM)||14.11|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
DaVita Kidney Care achieved another industry first by incorporating a secure telehealth platform, DaVita Care Connect™, into its home dialysis program. DaVita Care Connect™ is one of many connective technologies in its suite of services designed to improve outcomes and the care experience for patients choosing to treat at home.
Fresenius Medical Care (FMC) , the world's largest kidney dialysis provider, is confident the U.S. government will soften initial targets for treating patients with kidney disease at home rather than in dedicated centres. Chief Executive Rice Powell told Reuters a goal laid out by the U.S. Department of Health and Human Services (HHS) last July for 80% of new patients to undergo dialysis at home or receive organ transplants by 2025 was under review amid industry criticism. While Fresenius is developing less bulky and easier-to-use dialysis equipment and smartphone apps for home treatment, Powell said dialysis companies risked financial penalties if they kept patients who were deemed unsuitable for home treatment in dialysis centres under the new goals.
DaVita Kidney Care recently announced Kenny Gardner as its new chief people officer (CPO). Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.S.
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The company continues to focus on state policy, but will not pursue its own ballot initiative in California.
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 12.05% and -0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
DaVita (NYSE: DVA ) reported quarterly earnings of $1.86 per share on Monday, which beat the analyst consensus estimate of $1.66. This is a 106% increase over earnings of 90 cents per share from the same ...
On Monday, February 10, DaVita (NYSE: DVA ) will release its latest earnings report. Check out Benzinga's preview to understand the implications. Earnings and Revenue Analysts covering DaVita modeled for ...
Today we're going to take a look at the well-established DaVita Inc. (NYSE:DVA). The company's stock saw a significant...
Davita Inc (NYSE: DVA ) surged to all-time highs Friday after winning the praise of a new market advocate. Medicare is largely to thank. The Rating Goldman Sachs analysts led by Stephen Tanal upgraded ...
Warren Buffett, chairman and CEO of legendary holding company Berkshire Hathaway (BRK.B), is often called the greatest value investor of all time. Although Buffett identifies targets based on their "intrinsic value," a number of Berkshire's holdings look like cheap stocks by more prosaic value indicators, too.Not every stock held by Berkshire Hathaway is necessarily a bargain at its current share price. After all, Buffett has held some of these names for decades. To that end, we scoured Berkshire Hathaway's portfolio of nearly 50 stocks to find the ones that look like they're on sale these days.In some cases, we relied on forward price-to-earnings multiples, which show what a stock costs in light of its expected earnings growth. (The S&P; 500, by the way, trades at 18.6 times expected earnings, by Yardeni Research's calculations.) In others, we also took into consideration book values. And naturally we paid attention to long-term growth forecasts and fundamentals.After sorting through the Berkshire Hathaway equity portfolio with those criteria in mind, these 10 names stood out among the cheapest Warren Buffett stocks. SEE ALSO: Every Warren Buffett Stock Ranked: The Berkshire Hathaway Portfolio